REG-Gruss Capital Management: Form 8.3 - Steris Corporation <Origin Href="QuoteRef">STE.N</Origin> <Origin Href="QuoteRef">STWT.L</Origin> <Origin Href="QuoteRef">SYR.L</Origin>
24/08/2015 15:30
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Identity of the person whose positions/dealings are being Gruss Capital
disclosed: Management LLP
(b) Owner or controller of interests and short positions
disclosed, if different from 1(a):
The naming of nominee or vehicle companies is insufficient
(c) Name of offeror/offeree in relation to whose relevant Steris Corporation
securities this form relates:
Use a separate form for each offeror/offeree
(d) If an exempt fund manager connected with an offeror/offeree,
state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: 21/08/2015
(f) Has the discloser previously disclosed, or are they today Yes
disclosing, under the Code in respect of any other party to this If YES, specify which:
offer? Synergy Health Plc
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a) Interests and short positions in the relevant securities of the
offeror or offeree to which the disclosure relates following the dealing (if
any)
Class of relevant security:
Ordinary Shares
Interests Short positions
Number % Number %
(1) Relevant securities owned and/ -576,524 -0.96
or controlled:
(2) Derivatives (other than
options):
(3) Options and agreements to 200,000 0.33
purchase/sell:
200,000 0.33 -576,524 -0.96
TOTAL:
All interests and all short positions should be disclosed.
Details of any open derivative or option positions, or agreements to purchase
or sell relevant securities, should be given on a Supplemental Form 8 (Open
Positions).
(b) Rights to subscribe for new securities (including directors' and
other executive options)
Class of relevant security in relation to
which subscription right exists:
Details, including nature of the rights
concerned and relevant percentages:
If there are positions or rights to subscribe to disclose in more than one
class of relevant securities of the offeror or offeree named in 1(c), copy
table 2(a) or (b) (as appropriate) for each additional class of relevant
security.
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
(a) Purchases and sales
Class of relevant Purchase/sale Number of securities Price per unit
security
Ordinary Shares Sell 34,444 63.8499 USD
(b) Derivatives transactions (other than options)
Class of Product Nature of dealing Number of Price per unit
relevant description e.g. opening/closing a reference
security e.g. CFD long/short position, securities
increasing/reducing a
long/short position
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number of Exercise Type Expiry Option
relevant description purchasing, securities price per e.g. date money
security e.g. call selling, to which unit American, paid/
option varying etc. option European received
relates etc. per unit
Ordinary call option purchasing 200,000 70 American 18/09/ 0.6948
Shares 2015 USD
(ii) Exercising
Class of relevant Product description Number of securities Exercise price per
security e.g. call option unit
(d) Other dealings (including subscribing for new securities)
Class of relevant Nature of dealing Details Price per unit (if
security e.g. subscription, applicable)
conversion
The currency of all prices and other monetary amounts should be stated.
Where there have been dealings in more than one class of relevant securities of
the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may be
an inducement to deal or refrain from dealing entered into by the person making
the disclosure and any party to the offer or any person acting in concert with
a party to the offer:
If there are no such agreements, arrangements or understandings, state "none"
NONE
(b) Agreements, arrangements or understandings relating to options or
derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant
securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
NONE
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 24 August 2015
Contact name: Paul Lodge
Telephone number: +44 20 7518 9002
Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service and must also be emailed to the Takeover Panel at
monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is
available for consultation in relation to the Code's dealing disclosure
requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS,
AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
1. KEY INFORMATION
Full name of person making disclosure: Gruss Capital Management LLP
Name of offeror/offeree in relation to whose Steris Corporation
relevant securities the disclosure relates:
2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
Class of Product Written or Number of Exercise Type Expiry date
relevant description purchased securities to price per e.g.
security e.g. call which option unit American,
option or derivative European
relates etc.
Ordinary call option purchased 200,000 70 American 18/09/2015
Shares
3. AGREEMENTS TO PURCHASE OR SELL ETC.
Full details should be given so that the nature of the interest or
position can be fully understood:
The position is resultant from the purchase of 2,000 exchange traded
option contracts.
It is not necessary to provide details on a Supplemental Form (Open Positions)
with regard to cash-settled derivatives.
The currency of all prices and other monetary amounts should be stated.
The Panel's Market Surveillance Unit is available for consultation in relation
to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
END
Copyright © 2015 PR Newswire Association, LLC. All Rights ReservedRecent news on Steris
See all newsREG - Travelex Financing - Update on debt restructuring
AnnouncementREG - Synergy Health Steris Corp. - Scheme Effective <Origin Href="QuoteRef">STE.N</Origin> <Origin Href="QuoteRef">SYR.L</Origin>
AnnouncementREG - State Street Global Steris Corp. Synergy Health - Form 8.3 - Steris Corporation <Origin Href="QuoteRef">STE.N</Origin> <Origin Href="QuoteRef">SYR.L</Origin>
AnnouncementREG - Legal&Gen Inv Mgmnt Synergy Health Steris Corp. - Form 8.3 - Steris Corporation <Origin Href="QuoteRef">STE.N</Origin> <Origin Href="QuoteRef">SYR.L</Origin>
AnnouncementREG-BARCLAYS PLC FORM 8.3 - STERIS CORPORATION <Origin Href="QuoteRef">BARC.L</Origin> <Origin Href="QuoteRef">STE.N</Origin>
Announcement